fda warning bpc-157 not approved for human use FDA's Review Of Peptides Signals A Growing Public Health Challenge BPC-157: Experimental Peptide Creates Risk

Investigators are particularly interested in determining the mechanisms by which effects observed in murine models relate to broader mammalian metabolic regulation, and whether different experimental conditions (young vs aged models, healthy vs metabolically compromised states) show differential responses to NNMT inhibition

Patients with diabetes should be especially careful and avoid drinking around the time of the procedure

[DOI] [PubMed] [Google Scholar] 41.Mogulkoc R., Baltaci A.K., Oztekin E., Aydin L., Sivrikaya A

Again, no significant adverse events were reported

Importantly, AOD-9604 does not bind to growth hormone receptors, which is why it lacks the glucose-elevating and IGF-1-stimulating effects of full-length growth hormone